Sativa PLC’s (LON:SATI) revenues surged higher as demand rocketed for its range of CBD oil-based products and cannabis lab testing service.
Sales in the six months to June rose 133% to £588,000 from £252,000 in the previous six months and just £8,000 a year ago.
PhytoVista has become a recognised "go-to" laboratory for testing cannabidiol products, it said and has delivered in excess of 1,500 tests to external customers.
Since the half-year, Sativa has opened three Goodbody Wellness outlets in the West Country stocking more than 50 products such as CBD-infused coffee.
Rolling out of the rest of the chain has been affected by branding changes and sales initiative which will mean full-year revenue and underlying profit coming in below internal forecasts.
New chief executive Henry Lees-Buckley said: "Sativa made substantial progress during the first half of the year with revenue and gross profits growing strongly.
"The Goodbody CBD Wellness business completed its three-store pilot phase and is poised to roll-out its franchise model.
"With the George Botanicals brand and PhytoVista laboratories also performing well, prospects look good."
Losses for the half-year were £1.56mln, while Sativa had cash at the period end of £2.23mln.